Neogenomics (NEO) Inventory (2010 - 2026)

Neogenomics (NEO) has reported Inventory for 17 consecutive years, with $29.8 million the latest figure, recorded in Q1 2026.

• Inventory for Q1 2026 came in at $29.8 million, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.8 million (changed 0.22% YoY), and the FY2025 annual result was $28.6 million, up 6.8% from the prior year.
• Inventory was $29.8 million for Q1 2026 at Neogenomics, up from $28.6 million in the prior quarter.
• Over five years, Inventory peaked at $34.2 million in Q2 2025 and troughed at $20.3 million in Q1 2024.
• Average Inventory over 5 years is $25.7 million, with a median of $24.4 million recorded in 2023.
• Year-over-year, Inventory slipped 16.83% in 2024 and soared 47.2% in 2025.
• Over 5 years, Inventory stood at $24.3 million in 2022, then retreated by 0.5% to $24.2 million in 2023, then rose by 10.73% to $26.7 million in 2024, then gained by 6.8% to $28.6 million in 2025, then increased by 4.45% to $29.8 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $29.8 million in Q1 2026, $28.6 million in Q4 2025, and $28.5 million in Q3 2025.